AtG Therapeutics
About:
AtG Therapeutics specializes in the development of therapeutic techniques for cancer resistance to improve the lives of cancer patients.
Website: https://www.atgtx.com
Top Investors: ICF Capital, Inveniam, Blue Goose Capital, WA4STEAM
Description:
AtG is a spin-off company from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) in Barcelona that specialized in the discovery and development of new therapeutic techniques for cancer resistance to improve the lives of cancer patients.
Total Funding Amount:
756000 EUR
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-06-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai